Soufflé gets $135M for three RNA medicines
A Bob Langer-affiliated startup has collected a megaround to advance at least three experimental oligonucleotide medicines. Soufflé Therapeutics uncorked a fresh $135 million in VC backing on Tuesday. The capital will ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.